Tumor boards are meetings where physicians caring for patients with cancer and other providers meet to discuss specific patients and advise one another on the best treatment plans.
Under the direction of
Razelle Kurzrock, MD, UC San Diego Health and Moores Cancer Center have initiated a new, leading-edge type of tumor board that discusses patients with all types of cancer whose tumors have been analyzed with advanced genomic diagnostic tests. This new Molecular Tumor Board, working with our
Center for Personalized Cancer Therapy, enables us to translate the strong science at UC San Diego Health into recommendations for individual patient treatments.
The Molecular Tumor Board includes expert physicians and world-class scientists, including medical oncologists, surgeons, radiation therapists, researchers, geneticists and pathologists.
Razelle Kurzrock, MD
Senior Deputy Director for Clinical Science
Director, Center for Personalized Cancer Therapy
Barbara Parker, MD
Deputy Director for Clinical Affairs
Richard Schwab, MD
Associate Clinical Professor, Hematology/Oncology
The Molecular Tumor Board reviews a patient's information in order to discuss personalized cancer therapy. Pictured are, from left, co-moderator
Barbara Parker, MD, deputy director for clinical affairs; moderator
Razelle Kurzrock, MD, senior deputy director for clinical science and director of the Center for Personalized Cancer Therapy; co-moderator
Richard Schwab, MD, associate clinical professor of hematology/oncology;
Carl Hoh, MD, associate professor of radiology; and
Brian Datnow, MD, clinical professor of pathology.
The Molecular Tumor Board reviews a patient's medical information in order to discuss personalized cancer therapy options.